FEITENG SU: Open Payments
NPI 1477572733 · URBANA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,208 in 26 payments from 6 companies in 2025. Trend: 2023 $5,754 · 2024 $13,890 · 2025 $11,208
Speaker / faculty: $10,500Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $10,792 |
| E.R. Squibb & Sons, L.L.C. | 2 | $243 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Alkermes, Inc. | 1 | $63 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: UZEDY, COBENFY, ABILIFY ASIMTUFII, LYBALVI, FANAPT, INVEGA SUSTENNA.
Industry payments across IL — which companies pay providers there.
